G7
Payments companies reported to CMS as associated with G7. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with G7, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with G7
These are the largest totals companies reported as associated with G7. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rafael Sierra | Rochester, MN | Orthopaedic Surgery | $1,437,880.09 |
| William Long | Los Angeles, CA | Adult Reconstructive Orthopaedic Surgery | $636,387.78 |
| Matthew Squire | Aurora, IL | Orthopaedic Surgery | $636,387.78 |
| Michael Miller | Tucson, AZ | Adult Reconstructive Orthopaedic Surgery | $584,018.80 |
| Jonathan Yerasimides | Louisville, KY | Orthopaedic Surgery | $374,018.63 |
| Atul Kamath | Manasquan, NJ | Adult Reconstructive Orthopaedic Surgery | $264,745.79 |
| Charles Decook | Cumming, GA | Orthopaedic Surgery | $215,491.18 |
| Charles Lawrie | Miami, FL | Orthopaedic Surgery | $197,772.04 |
| Aldo Riesgo | Miami, FL | Orthopaedic Surgery | $189,747.86 |
| Khalid Yousuf | Plano, TX | Orthopaedic Surgery | $140,088.20 |
Prescribed G7?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.